Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPα capable of binding to human CD47.

Wang C, Wang H, Ide K, Wang Y, Van Rooijen N, Ohdan H, Yang YG.

Cell Transplant. 2011;20(11-12):1915-20. doi: 10.3727/096368911X566253. Epub 2011 Apr 29.

2.

The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.

Barclay AN, Van den Berg TK.

Annu Rev Immunol. 2014;32:25-50. doi: 10.1146/annurev-immunol-032713-120142. Epub 2013 Nov 6. Review.

PMID:
24215318
3.

The CD47-SIRPα signalling system: its physiological roles and therapeutic application.

Murata Y, Kotani T, Ohnishi H, Matozaki T.

J Biochem. 2014 Jun;155(6):335-44. doi: 10.1093/jb/mvu017. Epub 2014 Mar 12. Review.

PMID:
24627525
4.

CD47: a new player in phagocytosis and xenograft rejection.

Navarro-Alvarez N, Yang YG.

Cell Mol Immunol. 2011 Jul;8(4):285-8. doi: 10.1038/cmi.2010.83. Epub 2011 Jan 24. Review.

5.

Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.

Matozaki T, Murata Y, Okazawa H, Ohnishi H.

Trends Cell Biol. 2009 Feb;19(2):72-80. doi: 10.1016/j.tcb.2008.12.001. Epub 2009 Jan 12. Review.

PMID:
19144521
6.

[CD47 and leukemia stem cells].

Cheng QS, Wang XB.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):1088-91. Review. Chinese.

PMID:
20723335
7.

Role of CD47 in erythroid cells and in autoimmunity.

Oldenborg PA.

Leuk Lymphoma. 2004 Jul;45(7):1319-27. Review.

PMID:
15359629
8.

[Role of CD47 in hematologic malignancies].

Su GH, Zhao YL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1631-4. doi: 10.7534/j.issn.1009-2137.2013.06.050. Review. Chinese.

PMID:
24370062
9.

Innate immune 'self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation.

van den Berg TK, van der Schoot CE.

Trends Immunol. 2008 May;29(5):203-6. doi: 10.1016/j.it.2008.02.004. Epub 2008 Apr 3. Review.

PMID:
18394962
10.

Stimulatory and inhibitory receptor interactions in xenotransplantation.

Plege A, Schwinzer R.

Curr Opin Organ Transplant. 2010 Apr;15(2):219-23. doi: 10.1097/MOT.0b013e328336b8e5. Review.

PMID:
20075730
11.

CD47 in xenograft rejection and tolerance induction.

Yang YG.

Xenotransplantation. 2010 Jul-Aug;17(4):267-73. doi: 10.1111/j.1399-3089.2010.00601.x. Review.

12.

Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function.

Barclay AN.

Curr Opin Immunol. 2009 Feb;21(1):47-52. doi: 10.1016/j.coi.2009.01.008. Epub 2009 Feb 14. Review.

13.

Macrophages as mediators of tumor immunosurveillance.

Jaiswal S, Chao MP, Majeti R, Weissman IL.

Trends Immunol. 2010 Jun;31(6):212-9. doi: 10.1016/j.it.2010.04.001. Epub 2010 May 7. Review.

14.

The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications.

Chao MP, Weissman IL, Majeti R.

Curr Opin Immunol. 2012 Apr;24(2):225-32. doi: 10.1016/j.coi.2012.01.010. Epub 2012 Feb 4. Review.

15.

SIRP/CD47 signaling in neurological disorders.

Zhang H, Li F, Yang Y, Chen J, Hu X.

Brain Res. 2015 Oct 14;1623:74-80. doi: 10.1016/j.brainres.2015.03.012. Epub 2015 Mar 17. Review.

PMID:
25795378
16.

CD47 signaling pathways controlling cellular differentiation and responses to stress.

Soto-Pantoja DR, Kaur S, Roberts DD.

Crit Rev Biochem Mol Biol. 2015;50(3):212-30. doi: 10.3109/10409238.2015.1014024. Epub 2015 Feb 24. Review.

17.

CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Sick E, Jeanne A, Schneider C, Dedieu S, Takeda K, Martiny L.

Br J Pharmacol. 2012 Dec;167(7):1415-30. doi: 10.1111/j.1476-5381.2012.02099.x. Review.

18.

Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific 'Marker of Self' CD47, and target physical properties.

Sosale NG, Spinler KR, Alvey C, Discher DE.

Curr Opin Immunol. 2015 Aug;35:107-12. doi: 10.1016/j.coi.2015.06.013. Epub 2015 Jul 13. Review.

PMID:
26172292
19.

Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47.

Soto-Pantoja DR, Stein EV, Rogers NM, Sharifi-Sanjani M, Isenberg JS, Roberts DD.

Expert Opin Ther Targets. 2013 Jan;17(1):89-103. doi: 10.1517/14728222.2013.733699. Epub 2012 Oct 27. Review.

20.

Programmed cell removal: a new obstacle in the road to developing cancer.

Chao MP, Majeti R, Weissman IL.

Nat Rev Cancer. 2011 Dec 8;12(1):58-67. doi: 10.1038/nrc3171. Review.

PMID:
22158022
Items per page

Supplemental Content

Write to the Help Desk